Skip to content

Changes in serum uric acid during natural course of mania (baseline to 10 weeks) with usual care in patients with bipolar-I disorder

Assessment of serum uric acid and its association with short-term naturalistic course of manic episode in patients with bipolar I disorder - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/06/089110
Enrollment
100
Registered
2025-06-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F311- Bipolar disorder, current episodemanic without psychotic features

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

AIIMS NEW DELHI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria for cases 18 to 45 years and Meeting DSM 5 criteria for Bipolar 1 disorder current episode mania. Inclusion criteria for Controls comprise 18 to 45 years, and screen negative using PHQ-9 and GAD-

Exclusion criteria

Exclusion criteria: Exclusion criteria for Cases: 1. Any co occurring psychiatric illness or intellectual disability( as per known history) 2. Any current use of substance apart from nicotine ( as per known history) 3. Any known medical condition that has the potential to interfere with the the study assessments 4. Pregnancy or lactation 5. ECT in past 1 month Exclusion criteria for Controls: 1. GAD score>10 or PHQ-9 score>10 2. Any psychiatric illness or intellectual disability( as per known history) 3. Any current use of substance apart from nicotine ( as per known history) 4. Any known medical condition that has the potential to interfere with the the study assessments 5. Pregnancy or lactation

Design outcomes

Primary

MeasureTime frame
1) Assess and compare the serum uric acid across manic patients and matched healthy controls 2)Assess the clinical profile, including symptom severity and its association with serum uric acid in patients with mania at baseline and prospective follow-upTimepoint: Baseline, followed by 3 time points in next 10 weeks , that is week 2,4, and 10. Completers will be any 2 time points including baseline

Secondary

MeasureTime frame
Assess the clinical profile, including symptom severity and its association with serum uric acid in patients with mania at baseline and prospective follow-upTimepoint: Baseline, followed by 3 time points in next 10 weeks , that is week 2,4, and 10. Completers will be any 2 time points including baseline

Countries

India

Contacts

Public ContactDr Raman Deep

AIIMS, New Delhi

drramandeep@gmail.com26588500

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026